Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 31
Merck Argues for Preemption of Claims Concerning Post-VIGOR Label
La. Judge Refuses to Order Mistrial in Vioxx MDL Case
Widow Pled Valid Claims Against Prescribing Physician, Judge Says
Judge Denies Merck Motion to Postpone Deposition of Dr. Steven Nissen
Merck Seeks Transcript Expenses from Plaintiff Who Lost MDL Trial
Judge: Plaintiffs' Malpractice Claims Against Physicians Mandate Remand
Research Watch, Arthritis Drugs, December 2006
FDA Panel Recommends Approval of Celebrex for Juvenile Arthritis
